About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
SEC Form 8-K: Press Release dated January10, 2025
BPTH_20250110_8-K
SEC Form 8-K: Press Release dated December 19, 2024
BPTH_20241219_8-K
SEC Form 8-K: Other Items
BPTH_24-31094-1_D1.2_20241213
Download
SEC Form 8-K: Press Release dated December 11, 2024
BPTH_20241212_8-K
SEC Form 8-K: Other Events
BPTH_8-K_20241125
SEC Form 8-K: Press Release dated November 15, 2024
BPTH20241115_8-K
SEC Form 10-Q: For Period ending September 30, 2024
BPTH_20241114_10-Q
SEC ARS: Annual Report 2023
BPTH_20241024_ARS
SEC Form DEFA-14A: Additional Proxy Materials
BPTH_20241025_DEFA14A
SEC DEF-14A: Proxy Statement
BPTH_20241025_DEF_14A
About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us